Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Laurent Laforest (Lyon, France), Laurent Laforest, Alexandra L. Dima, Nathalie Texier, Marijn de Bruin, Gimena Hernandez, Maëva Nolin, Eric van Ganse and the ASTROLAB Group. Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data. Eur Respir J 2016; 48: Suppl. 60, 4209

Member's Comments

No comment yet.

Related content which might interest you: Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 One-year coverage by inhaled steroids in asthma: French claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Factors related with hospitalizations due to asthma exacerbations Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Barriers to adherence to asthma medication Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence? Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Agreement between patient-reported and chart documented outcomes: Case study in COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016